skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Collection of ICC arbitral awards = Recueil des sentences arbitrales de la CCI
Collection of ICC arbitral awards = Recueil des sentences arbitrales de la CCI
Material Type:
Livro 		Adicionar ao Meu Espaço

Collection of ICC arbitral awards = Recueil des sentences arbitrales de la CCI

Sigvard Jarvin; Yves Derains; Jean-Jacques Arnaldez; Dominique Hascher; International Chamber of Commerce

Paris ICC Pub. New York Deventer Boston Kluwer Law and Taxation Publishers c1990-<c1997 >

Localização: FD - Fac. Direito    (341.638 C668 v.1 reimpr. BGS DIN )(Acessar)

2
De vita Mosis
De vita Mosis
Material Type:
Livro 		Adicionar ao Meu Espaço

De vita Mosis

Philon D'Alexandrie Roger Arnaldez; Claude Mondésert; Jean Pouilloux; Pierre Savinel

Paris Cerf 1967

Localização: FFLCH - Fac. Fil. Let. e Ciências Humanas    (180 P567o v.22 pt.1/2 )(Acessar)

3
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response

Arnaldez, Fernanda I ; O'Day, Steven J ; Drake, Charles G ; Fox, Bernard A ; Fu, Bingqing ; Urba, Walter J ; Montesarchio, Vincenzo ; Weber, Jeffrey S ; Wei, Haiming ; Wigginton, Jon M ; Ascierto, Paolo Antonio

Journal for immunotherapy of cancer, 2020-05, Vol.8 (1), p.e000930 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
4
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Aggarwal, Charu ; Prawira, Amy ; Antonia, Scott ; Rahma, Osama ; Tolcher, Anthony ; Cohen, Roger B ; Lou, Yanyan ; Hauke, Ralph ; Vogelzang, Nicholas ; P Zandberg, Dan ; Kalebasty, Arash Rezazadeh ; Atkinson, Victoria ; Adjei, Alex A ; Seetharam, Mahesh ; Birnbaum, Ariel ; Weickhardt, Andrew ; Ganju, Vinod ; Joshua, Anthony M ; Cavallo, Rosetta ; Peng, Linda ; Zhang, Xiaoyu ; Kaul, Sanjeev ; Baughman, Jan ; Bonvini, Ezio ; Moore, Paul A ; Goldberg, Stacie M ; Arnaldez, Fernanda I ; Ferris, Robert L ; Lakhani, Nehal J

Journal for immunotherapy of cancer, 2022-04, Vol.10 (4), p.e004424 [Periódico revisado por pares]

England: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
5
Targeting the Insulin Growth Factor Receptor 1
Targeting the Insulin Growth Factor Receptor 1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting the Insulin Growth Factor Receptor 1

Arnaldez, Fernanda I., MD ; Helman, Lee J., MD

Hematology/oncology clinics of North America, 2012-06, Vol.26 (3), p.527-542 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth
Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth
Material Type:
Artigo 		Adicionar ao Meu Espaço

Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth

Yeung, C L ; Ngo, V N ; Grohar, P J ; Arnaldez, F I ; Asante, A ; Wan, X ; Khan, J ; Hewitt, S M ; Khanna, C ; Staudt, L M ; Helman, L J

Oncogene, 2013-11, Vol.32 (47), p.5429-5438 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS&#8211;FLI1 fusion transcript
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS&#8211;FLI1 fusion transcript
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS–FLI1 fusion transcript

Grohar, Patrick J. ; Glod, John ; Peer, Cody J. ; Sissung, Tristan M. ; Arnaldez, Fernanda I. ; Long, Lauren ; Figg, William D. ; Whitcomb, Patricia ; Helman, Lee J. ; Widemann, Brigitte C.

Cancer chemotherapy and pharmacology, 2017-09, Vol.80 (3), p.645-652 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
8
New Strategies in Ewing Sarcoma: Lost in Translation?
New Strategies in Ewing Sarcoma: Lost in Translation?
Material Type:
Artigo 		Adicionar ao Meu Espaço

New Strategies in Ewing Sarcoma: Lost in Translation?

ARNALDEZ, Fernanda I ; HELMAN, Lee J

Clinical cancer research, 2014-06, Vol.20 (12), p.3050-3056 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
9
Role of Fc&#947; receptors in HER2-targeted breast cancer therapy
Role of Fc&#947; receptors in HER2-targeted breast cancer therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Role of Fcγ receptors in HER2-targeted breast cancer therapy

Musolino, Antonino ; Gradishar, William J ; Rugo, Hope S ; Nordstrom, Jeffrey L ; Rock, Edwin P ; Arnaldez, Fernanda ; Pegram, Mark D

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003171 [Periódico revisado por pares]

England: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
10
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma

Heske, Christine M ; Davis, Mindy I ; Baumgart, Joshua T ; Wilson, Kelli ; Gormally, Michael V ; Chen, Lu ; Zhang, Xiaohu ; Ceribelli, Michele ; Duveau, Damien Y ; Guha, Rajarshi ; Ferrer, Marc ; Arnaldez, Fernanda I ; Ji, Jiuping ; Tran, Huong-Lan ; Zhang, Yiping ; Mendoza, Arnulfo ; Helman, Lee J ; Thomas, Craig J

Clinical cancer research, 2017-12, Vol.23 (23), p.7301-7311 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (49)
  2. Livros  (4)
  3. Resenhas  (3)
  4. Book Chapters  (2)
  5. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Arnaldez, J
  2. D'Alexandrie
  3. Jarvin, S
  4. Pouilloux, J
  5. Hascher, D

Neste Assunto:

  1. Life Sciences & Biomedicine
  2. Science & Technology
  3. Humans
  4. Oncology
  5. Female

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.